000 | 01969 a2200517 4500 | ||
---|---|---|---|
005 | 20250514073121.0 | ||
264 | 0 | _c20040415 | |
008 | 200404s 0 0 eng d | ||
022 | _a0957-5235 | ||
024 | 7 |
_a10.1097/00001721-200307000-00007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSørensen, Benny | |
245 | 0 | 0 |
_aReversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. _h[electronic resource] |
260 |
_bBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis _cJul 2003 |
||
300 |
_a469-77 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
650 | 0 | 4 |
_aCerebral Hemorrhage _xchemically induced |
650 | 0 | 4 | _aComputer Systems |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 |
_aFactor VII _xpharmacology |
650 | 0 | 4 | _aFactor VIIa |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHematoma _xchemically induced |
650 | 0 | 4 |
_aHemostatics _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInternational Normalized Ratio |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
650 | 0 | 4 | _aThrombelastography |
650 | 0 | 4 |
_aThromboembolism _xprevention & control |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVitamin K _xantagonists & inhibitors |
650 | 0 | 4 |
_aWarfarin _xadverse effects |
700 | 1 | _aJohansen, Peter | |
700 | 1 | _aNielsen, Gitte L | |
700 | 1 | _aSørensen, Jens C | |
700 | 1 | _aIngerslev, Jørgen | |
773 | 0 |
_tBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis _gvol. 14 _gno. 5 _gp. 469-77 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001721-200307000-00007 _zAvailable from publisher's website |
999 |
_c12632135 _d12632135 |